Hyderabad-based GCBC Vaccines has received WHO reapproval for its oral cholera vaccine, Shanchol, originally developed by Shantha Biotechnics. The move revives India’s role in ensuring global vaccine supply and supports public health efforts against recurring cholera outbreaks.
